Skip to main content

Evidence for an expanded hypertension care cascade in low- and middle-income countries: a scoping review

Abstract

Background

With nearly 90% of annual hypertension-related deaths occurring in low- and middle-income countries (LMICs), there is an urgent need to measure the coverage of health services that effectively manage hypertension. However, there is little agreement on how to define effective coverage and the existing hypertension care cascade (hypertension prevalence, percent aware, percent treated, and percent controlled) does not account for the quality of care received by patients. This study reviews definitions of effective coverage and service quality for hypertension management services and proposes an expanded hypertension care cascade to improve measurement of health systems performance.

Methods

A systematic scoping review of literature published in six electronic databases between January 2000 and October 2020 identified studies that defined effective coverage of hypertension management services or integrated dimensions of service quality into population-based estimates of hypertension management in LMICs. Findings informed an expanded hypertension care cascade from which quality-adjusted service coverage can be calculated to approximate effective coverage.

Results

The review identified 18 relevant studies, including 6 that defined effective coverage for hypertension management services and 12 that reported a measure of service quality in a population-based study. Based on commonly reported barriers to hypertension management, new steps on the proposed expanded care cascade include (i) population screened, (ii) population linked to quality care, and (iii) population adhering to prescribed treatment.

Conclusion

There is little consensus on the definition of effective coverage of hypertension management services, and most studies do not describe the quality of hypertension management services provided to populations. Incorporating aspects of service quality to the hypertension care cascade allows for the calculation of quality-adjusted coverage of relevant services, enabling an appropriate measurement of health systems performance through effective coverage.

Peer Review reports

Background

Hypertension, or raised blood pressure,Footnote 1 is a leading cause of global cardiovascular mortality and morbidity, which causes one-third of all deaths globally [1]. Between 2000 and 2010, the age-standardized prevalence of hypertension fell by 2.6% in high-income countries, but rose by 7.7% in low- and middle-income countries (LMICs) [2]. In 2015, 8.5 million deaths were attributed to hypertension, 88% of which occurred in LMICs, underscoring the need for increased attention to hypertension management in these settings [3]. Hypertension can be controlled at the primary care level with a combination of sustained lifestyle changes and relatively affordable pharmaceuticals; however, successful treatment requires continuous monitoring and interaction with the health system. Successful management of hypertension at the population level is indicative of strong health system provision of preventive services. Therefore, measuring the coverage of hypertension management services that result in sustained non-elevated blood pressure levels can indicate health system performance.

Optimally organized health systems provide people with access to needed health services without causing financial hardship, but unless these services are provided at a certain standard of quality, they may not improve population health. It is widely accepted that expanding the coverage of health services alone is not sufficient to improve population health in maternal and child health interventions [4, 5]. This phenomenon has rarely been studied in services to address chronic diseases, such as hypertension. Without considering service quality, measurements of service coverage, also known as “crude coverage”, are only weakly associated with the health benefits received by a population [6]. Effective coverage is a promising metric for evaluating program and health system performance because it captures whether individuals are receiving health services of sufficient quality to achieve optimal health improvements made possible by medical and behavioral interventions [7]. For hypertension management, measuring and striving to increase effective coverage of services can improve early detection and initiation of treatment, ultimately reducing the burden of stroke and other consequences of high blood pressure.

Despite the promise of effective coverage and agreement on its basic calculation (Effective Coverage = Utilization X Quality | Need) there is not yet consensus on how to operationalize its measurement, especially when accounting for quality [8]. Quality of care has three aspects according to the Donabedian framework: structure (the inputs and resources needed to provide care), process (the actions taken by providers and patients in the act of giving and receiving care) and outcomes (the changes in patient health), each of which can be used to calculate effective coverage [9, 10]. An early article proposed six distinct approaches for calculating effective coverage, ranging from tracking changes in biomarkers over time to using statistical models to estimate health outcomes while accounting for unobserved variables such as intervention quality (Additional file 1) [7]. Previous studies have calculated effective coverage by adjusting crude intervention coverage levels according to a measures of intervention quality, such as service readiness observed, quality of care provided, or health outcomes achieved [5, 11,12,13,14]. Few of these studies have measured the effective coverage of interventions to manage hypertension or other non-communicable diseases (NCDs). More work is needed to incorporate relevant measures of quality into standard measures of effective coverage, especially for health conditions with a steadily increasing burden of disease, like hypertension.

National and sub-national efforts to calculate effective coverage of services primarily use health outcomes as a measure of intervention quality. While this approach has the benefit of providing an estimate of the health gains directly experienced by populations, many factors beyond the reach of the health system impact health outcomes. These factors, or social determinants of health, are interrelated non-medical factors such as early life exposures, social status, employment, social support and/or exclusion, and stress, all of which can influence health outcomes [15]. Measures of effective coverage that only adjust for quality based on health outcomes capture the impact of these social determinants and therefore may not reflect the direct contributions of health system performance in improving population health. Effective coverage based on non-elevated blood pressure levels is therefore also an indicator of broader societal factors, rather than health system performance alone. Methods for calculating effective coverage that consider the quality of services provided by the health system (i.e., structural and process quality) address this shortcoming.

Historically, population-level progress towards controlled blood pressure has been measured in a more or less standard way in the United States and internationally since at least the 1980s using a care cascade framework [16,17,18]. The care cascade usually involves measuring blood pressure levels of individuals identified through a population-based survey and reporting the following measures in a stepwise fashion:

  1. (i)

    the prevalence of hypertension: the percent of population with elevated blood pressure readings on the day of the survey or reported using antihypertensive medicines,

  2. (ii)

    the awareness of hypertension: the percent of those classified as hypertensive who had been previously diagnosed by a health worker,

  3. (iii)

    the treatment of hypertension: the percent of hypertensives who report recently taking antihypertensive medicines, and

  4. (iv)

    the control of hypertension: the percent of hypertensives who report taking antihypertensive medication and have non-elevated pressure on the day of the survey.

This standardized hypertension care cascade, measured at the population level, has enabled several powerful systematic reviews and meta-analyses on hypertension management nationally, regionally, and globally [1, 2, 19,20,21]. Applying the care cascade to different population subgroups enables important analyses on equity gaps in provision of care. Authors have also adapted the care cascade to meet their needs by including additional steps, including, for example, the screening of hypertension between steps i and ii [22, 23]. While the existing hypertension care cascade framework does incorporate a key measure of outcome quality (hypertension control), it does not account for the quality of health services that contribute to improved health. For other interventions, mostly related to maternal and child health, cascades of care have recognized this gap and have been expanded to measure process quality, in turn enabling the measurement of effective coverage [6, 12]. The absence of process quality-related indicators in the hypertension care cascade prohibits its ability to adequately measure health system performance related to hypertension care beyond the use of outcome indicators.

Without understanding the coverage of quality-adjusted services and examining relevant inputs and processes, health services research cannot reveal the drivers of and barriers to successful hypertension management and improved health. Thus, supply-side factors, such as facility readiness, provider knowledge and practices, and other health systems characteristics, should be considered and incorporated within the hypertension care cascade. This study seeks to review definitions of effective coverage for hypertension management services, including how non-outcome quality measures have been incorporated into the hypertension care cascade in studies relevant for low- and middle-income countries. Based on these findings, improvements to the care cascade framework will be proposed to inform improved measures of effective coverage of hypertension management services. A scoping study methodology was employed to accomplish this research aim, as it is a broader topic where many different study designs might be applicable [24, 25].

Methods

The study followed Arksey and O’Malley’s process for conducting a scoping review, incorporating subsequent methodological advancements [24, 26]. One overarching research question was identified, specifically “how have measures of coverage of hypertension management services in LMICs considered aspects of service quality?”. Two sub-aims were identified, namely to describe how effective coverage of hypertension management has been defined and to describe how service quality has been incorporated into studies reporting hypertension cascades of care in LMICs. A review protocol is available upon request from the corresponding author.

To find relevant studies, we performed a search of electronic journals and databases including Scopus, EMBASE, PubMed, ScienceDirect, ProQuest, and Web of Science using keywords “hypertension” and “effective coverage” or “care cascade” and its variants. An additional search was conducted in a subset of databases to include published studies that included aspects of hypertension management (e.g. prevalence, treatment, and control) but did not mention the care cascade by name (see Additional file 2 for search strategy). The search strategy was calibrated to ensure that three pre-identified “tracer” articles that discussed effective coverage of hypertension management services were included in results [27,28,29]. These searches were conducted on 12 and 26 October 2020 and were supplemented by periodic searches of grey literature databases (Google Scholar, New York Academy of Medicine Library, and World Bank eLibrary) for additional information.

Identified data were collated, duplicate articles were removed, and titles and abstracts were screened for relevance in the Cochrane Community’s screening and data extraction tool, Covidence [30]. Relevant studies identified through title and abstract screening included those that (i) mentioned hypertension in the title, (ii) were conducted in a low- or middle-income country according to 2018 World Bank classifications, (iii) reported on data collected since 2000, (iv) were associated with a full-text manuscript in English (conference abstracts and commentaries were excluded but corresponding authors were contacted when possible), (v) used a population-representative study design (which is necessary to calculate coverage of a service in the general population), and (vi) reported sufficient information to calculate coverage. Any relevant study that mentioned “effective coverage” in the title or abstract was automatically included in the full-text review. Studies were excluded during the full-text review if they (i) did not report any measure of quality, (ii) reported on pregnancy-related hypertension, (iii) reported on specific populations (not age-related) that preclude generalization to entire populations, or (iv) included the phrase “effective coverage” but did not define the concept specifically for hypertension management services.

The full-text of selected studies was reviewed and relevant information (on study type, data sources, definition of effective coverage, incorporation of service quality, among others) was extracted in the online survey platform, Qualtrics [31]. At the title and abstract screening and full-text review stages, two reviewers examined each article, and conflicts were discussed and resolved by the lead author. Findings were summarized in tables that demonstrated (i) how “effective coverage” of hypertension management has been defined, and (ii) how dimensions of service quality have been incorporated into studies reporting population-level coverage of hypertension management services. For mixed methods studies, thematic synthesis was used to identify the largest relative challenges to providing quality care according to the Donabedian framework within qualitative results [32]. The quality of included articles was assessed using the Appraisal tool for Cross-Sectional Studies (AXIS) (Additional file 3) [33]. Findings were used to propose additional steps on the hypertension care cascade, including methods to improve the measurement of effective coverage for health systems performance evaluation, by comparing and aligning major gaps in effective coverage found in the literature with other models of expanded care cascades [4, 6, 12]. Finally, the revised framework was shared with a group of six experts which included cardiologists, providers with experience working in LMICs, and public health experts (on effective coverage and population-based hypertension management) purposively selected from among faculty and practitioners with affiliation with the primary academic institution where the research was based. Their oral feedback was collected over 3 review meetings which involved oral presentations by the first author, and further written feedback was collected via email communication. Feedback was incorporated to improve the overall framework.

Results

Findings from the scoping review

Across the databases, 5,045 records were identified, including 3,670 unique records that were screened for relevance. After title and abstract screening, 585 relevant records were assessed for eligibility for full-text review. Of these, 264 full-text records were reviewed, and 18 records were included that defined effective coverage of hypertension services (n = 6) or incorporated measures of service quality into their findings (n = 12) (Fig. 1). On the AXIS scale for rating the quality of observational studies, the 18 studies that informed the expanded hypertension care cascade were generally of high quality, scoring an average of 16.2 out of 20 (with scores ranging from 9 to 20).

Fig. 1
figure 1

PRISMA flow diagram. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analysis

Studies that defined effective coverage took place in China, Mexico, and Thailand and were published between 2006 and 2020 (Table 1). Among the five studies that reported crude and effective coverage, the average difference in coverage estimate was 17.0% (Fig. 2). All six of the articles defining effective coverage reported some measure of outcome quality in their definition of effective coverage; however, there were differences in the way effective coverage was operationalized. Definitions of effective coverage included measures of actual reduction in blood pressure over target reduction [27, 34], the percent of the hypertensive population taking medication and achieving blood pressure control [28, 35], and the percent of the hypertensive population experiencing potential health gains (avoidance of hypertension-related hospitalization) [36]. One study considered a package of hypertension screening-related interventions and defined effective coverage for specific aspects of a national hypertension screening program [29]. Three of the studies defined effective coverage for hypertension management services in addition to other health services within the context of evaluating overall health systems performance [27, 28, 36]. Cross-sectional data sources were used in the majority of studies (5 out of 6), and longitudinal data sources were used in one study [34]. Out of the six studies, only one study reported any quality measure other than outcome quality. This study reported process quality indicators on the various screening-related services that were received by certain population segments in need [29].

Table 1 Definitions of effective coverage of services to measure hypertension
Fig. 2
figure 2

Reported differences in crude and effective coverage of hypertension management services

The studies that considered coverage of hypertension services adjusted for aspects of service quality were published between 2007 and 2020 and took place across nine countries: Bangladesh, Brazil, Cuba, India, Kenya, South Africa, Tajikistan, Tanzania, and Uganda (Table 2). Only one study was representative at the national level [38]. Five studies incorporated measures of process quality, four studies incorporated measures of structural quality, and three studies described measures of both process and structural quality.

Table 2 Studies that incorporate service quality into measures of coverage

The most common study designs were mixed methods designs that paired quantitative population-based survey data with qualitative information collected from patients and/or providers. Mixed methods studies that incorporated qualitative data from patients described structural quality issues such long wait times, lack of drugs, and poor adherence, and outcome quality issues related to patient satisfaction (e.g. poor perceived quality of services) [46, 48, 49]. Providers described a lack of appropriate equipment, stockouts of medicines, and insufficient time to counsel patients on lifestyle advice [42, 45]. Studies that used linked population-based survey study designs with information collected in facilities were able to provide quantitative estimates about these structural quality constraints. Cross-sectional household surveys were also frequently used to understand additional information about hypertension treatment, primarily focusing on availability of health services (including screening and diagnosis), the specific types of medication taken, adherence to treatment, and patient satisfaction.

Although five studies did not explicitly define a care cascade and four studies used steps from the standard hypertension care cascade, three recently published studies proposed alternative hypertension care cascades. One study separated treatment into service initiation and continued treatment [46]. Another included supply-side considerations, namely contact with the health system (service availability) and the receipt of continuous, high-quality treatment (quality-adjusted treatment) [38]. The third study linked detailed information from a hypertension screening and management intervention with a household survey, included multiple steps related to screening, referral to care, linkage to care within two years, retention in care, and then characteristics about the care provided during provider interactions [44]. Of note, a series of World Bank reports on cascades of care for hypertension that identified supply- and demand-side bottlenecks to achieving hypertension control were identified through grey literature searches, which are presented as a supplementary table (Additional file 4).

The structure- and process-related quality features identified in the articles fall into three main categories: facility readiness (related to structural quality including equipment, medicines, and human resources), content of care (related to process quality including adherence to treatment protocols, type of pharmacological treatment prescribed, and health advice given), and patient adherence to treatment (relating to process quality including adherence to medicines and retention in care).

Proposal for an expanded cascade of hypertension care

An expanded cascade of hypertension care is proposed that builds on previous standardized frameworks by incorporating additional steps to indicate the effectiveness of screening and treatment services provided by the health system (Fig. 3). Three new steps are proposed in the expanded hypertension care cascade: the percent of hypertensives that have ever had their blood pressure measured (to reflect facility readiness through frequency of blood pressure screening and early diagnosis), the percent of hypertensives linked to quality care (to reflect the content of care provided by the health system), and adherence to prescribed treatment regimens. From the expanded hypertension care cascade, an estimate of effective coverage (via quality-adjusted service coverage) can be calculated by taking the percent of individuals linked to quality care over the true population in need. Quality, use and need as applied to the expanded hypertension care cascade should be heuristically defined based on the health services delivery system in question, and the prioritized interventions for hypertension management being provided within that system.

Fig. 3
figure 3

Proposed expanded hypertension care cascade

While the proposed framework does not yet include standardized metrics for measuring quality of care or patient adherence, some potential measurement methods are proposed based on the results of this review (Table 3). Linkage to quality care may refer to the availability of drugs and blood pressure monitoring devices (structural quality), provider fidelity to standard treatment guidelines including prescribing practices and patient adherence (process quality), and/or patient satisfaction (outcome quality other than blood pressure control) among others. These can be measured by including additional questions in population-based surveys or through studies that link findings from household surveys (which provide information on service utilization and health outcomes) and facility-based surveys (which provide information on service quality). Patient adherence can include retention in care over time, adherence to lifestyle modification advice, and/or adherence to medication. These can be incorporated as additional questions in household surveys or through more complex methods like pill counts or treatment diaries. Even without standardized measurements of quality of care and patient adherence, it is hoped that the proposed framework can promote the consideration of intermediate outcomes such as fidelity to treatment protocols and regimens when examining population coverage of hypertension services. This consideration will also help to advance the conceptualization of process quality within effective coverage of hypertension management services, contributing to a standardized metric which will help improve health systems performance measurement.

Table 3 Proposed expanded hypertension care cascade description

Discussion

Hypertension is now more prevalent in LMICs than high-income countries, contributing to 7.5 million associated deaths in these countries each year [50]. Despite the massive burden of hypertension, only six studies have attempted to measure the effective coverage of hypertension management services in LMICs since 2000. This is a dearth of research relative to the 36 studies reporting effective coverage for reproductive, maternal, neonatal, and child health-related interventions found by a contemporary review [6]. The large difference in estimated crude and effective coverage within countries indicates the massive variability introduced when effective coverage for hypertension management services is calculated using non-standardized methods.

Researchers more frequently employ the hypertension care cascade than effective coverage to identify bottlenecks in achieving effective hypertension management; however, studies that provide insight into structural and process quality for hypertension management services received by populations are limited. In LMICs, the two largest gaps in the standard hypertension care are in the diagnosis of hypertension and achieving blood pressure control after treatment [20]. There is a critical need to scale up systemic strategies and interventions to target strategic points along the care cascade to improve population blood pressure control. Gaps remain in the standard hypertension care cascade, as the cascade measures the coverage of hypertension control, without accounting for the effect of health system-related services that contribute to effective management. This is the first study to systematically categorize the service quality-related aspects of the care cascade and propose an expanded care cascade based on these findings. Expanding the care cascade framework to incorporate measures of both screening- and treatment-related process quality will help directly identify service bottlenecks across the continuum of hypertension management services. This expanded framework also bridges the gap between the often-reported care cascade and the emerging conceptualization of effective coverage by providing an indication of quality-adjusted coverage of hypertension management services.

Previous efforts have characterized steps in care cascades where health benefits can be lost on the pathway to effective coverage; however, these have not been applied to hypertension care cascades [4, 6, 12]. The proposed new steps enable the quantification of missed opportunities for hypertension management based on access to care and the calculation of quality-adjusted coverage (E/A) and user-adherence-adjusted coverage of hypertension management services (F/A). They also enable a more comprehensive approach to studying effective coverage of these services beyond health outcomes alone.

There are some potential drawbacks to the expanded hypertension care cascade. One of the major bottlenecks described in the reviewed studies was a lack of facility readiness and structural quality. The percent of population ever screened (step B) is envisioned to be an indicator of facility readiness (to provide blood pressure screening services). However, there are shortcomings in this step’s ability to fully describe facility readiness. For example, the proposed step does not indicate how recently the individual has been screened for high blood pressure, which has implications for timely diagnosis of hypertension. Further, it does not indicate the quality of the screening services provided (e.g., whether correct cuff size is used, whether blood pressure measured twice) which has a large influence on whether or not a correct diagnosis is made. Another drawback is that certain steps are linked to locally relevant factors. Specifically, step E relies on hypertension management services being provided according to standards, which may vary locally, and step G may rely on a context-specific definition of non-elevated blood pressure (e.g., 140/90 mmHg vs 130/80 mmHg based on locally accepted guidelines). The proposed expanded care cascade should be further discussed by a global team of researchers to reach consensus on how to operationalize this framework in future research.

Evidence for the expanded hypertension care cascade came from studies conducted in 12 countries across five of the six WHO regions. To ensure consistency in future reporting of effective coverage of hypertension management, it will be important to incorporate perspectives of patients, researchers, and policymakers from multiple contexts when agreeing on international guidelines. As demonstrated by this review, there is currently no consensus among researchers on what constitutes effective coverage of hypertension management services. Further, the expanded hypertension care cascade can be applied to high-income countries, which similarly face challenges in providing effective hypertension management; fewer than half of hypertensive men and women achieve blood pressure control in high-income countries [51]. In the full-text review, two articles from Japan also reported gaps in the effective coverage of hypertension management services, emphasizing the need for additional research in high-income countries [52, 53]. Consensus across countries from multiple income groups and geographies will be necessary to track progress towards health systems functions that effectively manage a major contributor to the global burden of disease.

This study should be considered within its limitations. First, the search strategy excluded studies that did not provide population-representative estimates of hypertension management service coverage. Qualitative studies that examined the extent of provider knowledge relevant to hypertension treatment were therefore excluded [54, 55]. Several representative facility-based studies examined aspects of quality hypertension care, but without linking to a population-level survey, the percent of the population receiving these services, and thus the effective coverage, was unknown [56, 57]. Such linked study designs are common in the maternal and child health literature and should be increasingly used to determine quality-adjusted coverage for non-communicable disease management [11, 58,59,60]. Existing national household and facility-based surveys can be redesigned to encourage greater interoperability, which would add value to the hypertension care cascade and other program delivery analyses by enabling linked supply- and demand-side analysis. Second, the final results did not include studies published in languages other than English. At least one study was found in Spanish that included a definition of effective coverage of hypertension but was excluded [61]. Due to commonalities in authorship and study area with another included article, it is likely that the findings from this article are reflected in the results [27]. Third, this study is a review of the quality of hypertension management services, as characterized by the Donabedian quality framework, and is not intended to be a comprehensive review of all issues related to measuring effective coverage or quality. With new guidelines suggesting that the ideal threshold blood pressure is under 130/80 mmHg, the population in need of hypertension services and the hypertensive population with controlled blood pressure will drastically change [62]. Studies that have examined the effects of applying these guidelines report increases in hypertension prevalence ranging from 17.6% to 23.8% [63,64,65]. Additionally, certain aspects of quality such as equity, patient-centeredness, and efficiency are not comprehensively addressed in this review [66]. Future studies can apply the expanded cascade of care to different population sub-groups to enable equity analyses on receipt of quality services, and link cascades with information on health system expenditure and patient perspectives on care to reveal the effects of various guidelines and reforms on effective coverage.

Conclusion

This study reviewed the evidence on effective coverage for hypertension management and more broadly, quality within the hypertension care cascade. Although there is no consensus definition of effective coverage and indicators of quality vary by study, there are some common approaches to describing barriers on the pathway to effective coverage of hypertension management services. These approaches have been incorporated into an expanded hypertension care cascade framework that considers aspects of structural and process quality. Future studies should incorporate aspects of service quality in population measures of hypertension management coverage in LMICs. It is also necessary to improve our understanding of how interventions can improve intermediate outcomes in hypertension management (e.g. expansion of screening services, fidelity to treatment guidelines, and medication adherence). These studies are essential for understanding how to best align interventions and health systems to combat the high prevalence of hypertension in LMICs. This approach of studying effective coverage and quality-adjusted cascades of care helps to advance measurement of health systems performance, ultimately improving the quality of life for people with chronic diseases living in LMICs.

Availability of data and materials

The citation information of all articles included in the full-text review is included in Additional file 5. Additional materials, such as data collection forms, data extracted from included studies, data used for all analyses, and analytic code are available upon reasonable request to the corresponding author.

Notes

  1. Specifically, hypertension is defined as an individual with systolic blood pressure of 140 mm Hg or more and/or diastolic blood pressure of 90 mm Hg or more and/or taking antihypertensive medication.

Abbreviations

AXIS:

Appraisal tool for Cross-Sectional Studies

DTP:

Diphtheria, Tetanus, and Pertussis

HTN:

Hypertension

LMICs:

Low- and Middle-Income Countries

NCDs:

Non-Communicable Diseases

PRISMA:

Preferred Reporting Items for Systematic Reviews

References

  1. Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan MJ, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017;389(10064):37–55.

    Article  Google Scholar 

  2. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation [Internet]. 2016 Aug;134(6):441–50. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L72180569&from=export

  3. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol [Internet]. 2021;0123456789. Available from: http://dx.doi.org/https://doi.org/10.1038/s41569-021-00559-8

  4. Tanahashi T. Health service coverage and its evaluation. Bull World Health Organ. 1978;56(2):295–303.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Leslie HH, Malata A, Ndiaye Y, Kruk ME. Effective coverage of primary care services in eight high-mortality countries. BMJ Glob Heal. 2017;2(3): e000424.

    Article  Google Scholar 

  6. Amouzou A, Leslie HH, Ram M, Fox M, Jiwani SS, Requejo J, et al. Advances in the measurement of coverage for RMNCH and nutrition: from contact to effective coverage. BMJ Glob Heal. 2019;4(Suppl 4): e001297.

    Article  Google Scholar 

  7. Ng M, Fullman N, Dieleman JL, Flaxman AD, Murray CJL, Lim SS. Effective coverage: a metric for monitoring Universal Health Coverage. PLoS Med. 2014;11(9):e1001730.

    Article  Google Scholar 

  8. Shengelia B, Tandon A, Adams OB, Murray CJL. Access, utilization, quality, and effective coverage: An integrated conceptual framework and measurement strategy. Soc Sci Med. 2005;61(1):97–109.

    Article  Google Scholar 

  9. Donabedian A. Evaluating the Quality of Medical Care. Milbank Mem Fund Q. 1966;44(3):166.

    Article  Google Scholar 

  10. Donabedian A. The Quality of Care: How Can It Be Assessed? JAMA J Am Med Assoc. 1988;260(12):1743–8.

    CAS  Article  Google Scholar 

  11. Nguhiu PK, Barasa EW, Chuma J. Determining the effective coverage of maternal and child health services in Kenya, using demographic and health survey data sets: tracking progress towards universal health coverage. Trop Med Int Health. 2017;22(4):442–53.

    Article  Google Scholar 

  12. Marsh AD, Muzigaba M, Diaz T, Requejo J, Jackson D, Chou D, et al. Effective coverage measurement in maternal, newborn, child, and adolescent health and nutrition: progress, future prospects, and implications for quality health systems. Vol. 8, The Lancet Global Health. Elsevier Ltd; 2020. p. e730–6.

  13. Colson KE, Zúñiga-Brenes P, Ríos-Zertuche D, Conde-Glez CJ, Gagnier MC, Palmisano E, et al. Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamérica 2015. McVernon J, editor. PLoS One [Internet]. 2015 Jul 2 [cited 2021 Apr 1];10(7):e0130697. Available from: https://dx.plos.org/https://doi.org/10.1371/journal.pone.0130697

  14. Jannati A, Sadeghi V, Imani A, Saadati M. Effective coverage as a new approach to health system performance assessment: A scoping review. BMC Health Serv Res [Internet]. 2018 Nov 23 [cited 2019 Sep 30];18(1):886. Available from: https://bmchealthservres.biomedcentral.com/articles/https://doi.org/10.1186/s12913-018-3692-7

  15. Marmot M. Social determinants of health inequalities. Lancet. 2005;365(9464):1099–104.

    Article  Google Scholar 

  16. Cummings KM, Kirscht JP, Binder LR, Godley A. Prevalence, awareness, treatment, and control of hypertension in the inner city. Prev Med (Baltim). 1982;11:571–82.

    CAS  Article  Google Scholar 

  17. National Heart Blood and Lung Institute. Hypertension prevalence and the status of awareness, treatment, and control in the United States. Hypertension. 1985;7(3).

  18. Chadha SL, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath N. Prevalence, awareness & treatment status of hypertension in urban population of Delhi. Indian J Med Res. 1990;92:233–40.

    CAS  PubMed  Google Scholar 

  19. Bosu WK. Epidemic of hypertension in Ghana: a systematic review. BMC Public Health. 2010;10:418.

    Article  Google Scholar 

  20. Geldsetzer P, Manne-Goehler J, Marcus M-EME, Ebert C, Zhumadilov Z, Wesseh CS, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet [Internet]. 2019;394(10199):652–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070935450&doi=10.1016%2FS0140-6736%2819%2930955-9&partnerID=40&md5=2ede14adde659a1803ecf5b535d0da2d

  21. Akl C, Akik C, Ghattas H, Obermeyer CM. The cascade of care in managing hypertension in the Arab world: A systematic assessment of the evidence on awareness, treatment and control. BMC Public Health. 2020;20(1):1–13.

    Article  Google Scholar 

  22. Prenissl J, Manne-Goehler J, Jaacks LM, Prabhakaran D, Awasthi A, Bischops AC, et al. Hypertension screening, awareness, treatment, and control in India: A nationally representative cross-sectional study among individuals aged 15 to 49 years. Kruk ME, editor. PLoS Med [Internet]. 2019 May 3 [cited 2019 Nov 15];16(5):e1002801. Available from: http://dx.plos.org/https://doi.org/10.1371/journal.pmed.1002801

  23. Agho KE, Osuagwu UL, Ezeh OK, Ghimire PR, Chitekwe S, Ogbo FA. Gender differences in factors associated with prehypertension and hypertension in Nepal: A nationwide survey. PLoS One [Internet]. 2018;13(9). Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L623855336&from=export

  24. Arksey H, O’Malley L. Scoping studies: Towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8(1):19–32.

    Article  Google Scholar 

  25. Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. https://doi.org/10.1186/s12874-018-0611-x.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Levac D, Colquhoun H, O’Brien KK. Scoping studies: Advancing the methodology. Implement Sci. 2010;5(1):1–9.

    Article  Google Scholar 

  27. Lozano R, Soliz P, Gakidou E, Abbott-Klafter J, Feehan DM, Vidal C, et al. Benchmarking of performance of Mexican states with effective coverage. Lancet. 2006;368(9548):1729–41.

    Article  Google Scholar 

  28. Liu Y, Rao K, Wu J, Gakidou E. China’s health system performance. Lancet. 2008;372(9653):1914–23. https://doi.org/10.1016/S0140-6736(08)61362-8.

    Article  PubMed  Google Scholar 

  29. Charoendee K, Sriratanaban J, Aekplakorn W, Hanvoravongchai P. Assessment of population coverage of hypertension screening in Thailand based on the effective coverage framework. BMC Health Serv Res. 2018;18(1):1–9.

    Article  Google Scholar 

  30. Veritas Health Innovation. Covidence systematic review software. Melbourne, Australia

  31. Qualtrics [Internet]. Provo, Utah; 2005. Available from: www.qualtrics.com

  32. Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8(1):1–10. https://doi.org/10.1186/1471-2288-8-45.

    Article  Google Scholar 

  33. Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6(12):e011458.

    Article  Google Scholar 

  34. Zhao Y, Mahal AS, Tang S, Haregu TN, Oldenburg B. Effective coverage for hypertension treatment among middle-aged adults and the older population in China, 2011 to 2013: A nationwide longitudinal study. J Glob Health [Internet]. 2020;10(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083022535&doi=10.7189%2Fjogh.10.010805&partnerID=40&md5=202b0dba13557153bdc335b1c1318aa1

  35. Arredondo A, Azar A, Recaman AL. Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: Evidence and lessons from Mexico. Global Health [Internet]. 2018;14(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052066196&doi=10.1186%2Fs12992-018-0404-3&partnerID=40&md5=a6883ed5b1f20628cd7baea565c00cce

  36. Leslie HH, Doubova S V, Pérez-Cuevas R. Assessing health system performance: Effective coverage at the Mexican Institute of Social Security. Health Policy Plan [Internet]. 2019;34:II67–76. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074960984&doi=10.1093%2Fheapol%2Fczz105&partnerID=40&md5=f948ae4753901eafe570e3818cd2badc

  37. Arredondo A, Azar A, Recaman AL. Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: Evidence and lessons from Mexico. Global Health. 2018;14(1):1–10.

    Article  Google Scholar 

  38. Macinko J, Leventhal DGP, Lima-Costa MF. Primary Care and the Hypertension Care Continuum in Brazil. J Ambul Care Manage. 2018;41(1):34–46.

    Article  Google Scholar 

  39. Khanam MA, Lindeboom W, Koehlmoos TL, Alam DS, Niessen L, Milton AH. Hypertension: adherence to treatment in rural Bangladesh–findings from a population-based study. Glob Health Action. 2014;7:25028. https://doi.org/10.3402/gha.v7.25028.

    Article  PubMed  Google Scholar 

  40. Londoño Agudelo E, Rodríguez Salvá A, Díaz Piñera A, García Roche R, De Vos P, Battaglioli T, et al. Assessment of hypertension management and control: a registry-based observational study in two municipalities in Cuba. BMC Cardiovasc Disord. 2019;19(1):29.

    Article  Google Scholar 

  41. Bhandari S, Sarma PS, Thankappan KR. Adherence to antihypertensive treatment and its determinants among urban slum dwellers in Kolkata, India. Asia-Pacific J public Heal. 2015 Mar;27(2):NP74–84.

  42. Gabert R, Ng M, Sogarwal R, Bryant M, Deepu RV, McNellan CR, et al. Identifying gaps in the continuum of care for hypertension and diabetes in two Indian communities. BMC Health Serv Res. 2017;17(1):1–11.

    Article  Google Scholar 

  43. Jayanna K, Swaroop N, Kar A, Ramanaik S, Pati MK, Pujar A, et al. Designing a comprehensive Non-Communicable Diseases (NCD) programme for hypertension and diabetes at primary health care level: evidence and experience from urban Karnataka, South India. BMC Public Health. 2019;19(1):409.

    Article  Google Scholar 

  44. Heller DJ, Balzer LB, Kazi D, Charlebois ED, Kwarisiima D, Mwangwa F, et al. Hypertension testing and treatment in Uganda and Kenya through the SEARCH study: An implementation fidelity and outcome evaluation. PLoS One [Internet]. 2020;15(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077940790&doi=10.1371%2Fjournal.pone.0222801&partnerID=40&md5=abd12cb2aa57f5d99bbe8458ac2e392d

  45. Thorogood M, Connor MD, Hundt GL, Tollman SM. Understanding and managing hypertension in an African sub-district: A multidisciplinary approach. Scand J Public Health. 2007;35(SUPPL. 69):52–9. https://doi.org/10.1080/14034950701355411.

    Article  Google Scholar 

  46. Chukwuma A, Gong E, Latypova M, Fraser-Hurt N. Challenges and opportunities in the continuity of care for hypertension: A mixed-methods study embedded in a primary health care intervention in Tajikistan. BMC Health Serv Res. 2019;19(1):1–13.

    Article  Google Scholar 

  47. Zack RM, Irema K, Kazonda P, Leyna GH, Liu E, Spiegelman D, et al. Determinants of high blood pressure and barriers to diagnosis and treatment in Dar es Salaam, Tanzania. J Hypertens. 2016;34(12):2353–64. https://doi.org/10.1097/HJH.0000000000001117.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  48. Galson SW, Staton CA, Karia F, Kilonzo K, Lunyera J, Patel UD, et al. Epidemiology of hypertension in Northern Tanzania: A community-based mixed-methods study. BMJ Open. 2017;7(11):S110-1. https://doi.org/10.1136/bmjopen-2017-018829.

    Article  Google Scholar 

  49. Wollum A, Gabert R, McNellan CR, Daly JM, Reddy P, Bhatt P, et al. Identifying gaps in the continuum of care for cardiovascular disease and diabetes in two communities in South Africa: Baseline findings from the HealthRise project. PLoS One [Internet]. 2018;13(3). Available from: http://dx.doi.org/https://doi.org/10.1371/journal.pone.0192603

  50. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol 2021 1811 [Internet]. 2021 May 28 [cited 2022 May 18];18(11):785–802. Available from: https://www.nature.com/articles/s41569-021-00559-8

  51. Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet [Internet]. 2021 Sep 11 [cited 2022 May 27];398(10304):957–80. Available from: http://www.thelancet.com/article/S0140673621013301/fulltext

  52. Ikeda N, Nishi N, Sugiyama T, Noda H, Noda M. Effective coverage of medical treatment for hypertension , diabetes and dyslipidaemia in Japan : An analysis of National Health and Nutrition Surveys 2003 – 2017. 2020;

  53. Hashiguchi K, Nagata T, Mori K, Nagata M, Fujino Y, Ito M. Occupational health services improve effective coverage for hypertension and diabetes mellitus at Japanese companies. J UOEH. 2019;41(3):271–82.

    Article  Google Scholar 

  54. Neupane D, Mclachlan CS, Gautam R, Mishra SR, Thorlund M, Schlütter M, et al. Literacy and motivation for the prevention and control of hypertension among female community health volunteers: a qualitative study from Nepal. Glob Health Action. 2015;8:28254.

    Article  Google Scholar 

  55. Vedanthan R, Tuikong N, Hutchinson C, Blank E, Kamano JH, Kimaiyo S, et al. Barriers and facilitators to nurse management of hypertension in rural Western Kenya: A qualitative analysis. Glob Heart. 2014;9(1):e261-2. https://doi.org/10.1016/j.gheart.2014.03.2157.

    Article  Google Scholar 

  56. Mbui JM, Oluka MN, Guantai EM, Sinei KA, Achieng L, Baker A, et al. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications. Expert Rev Clin Pharmacol. 2017;10(11):1263–71. https://doi.org/10.1080/17512433.2017.1371590.

    CAS  Article  PubMed  Google Scholar 

  57. Gala P, Moshokgo V, Seth B, Ramasuana K, Kazadi E, Rudy M, et al. Medication Errors and Blood Pressure Control Among Patients Managed for Hypertension in Public Ambulatory Care Clinics in Botswana. J Am Heart Assoc. 2020;1–10.

  58. Kanyangarara M, Munos MK, Walker N. Quality of antenatal care service provision in health facilities across sub – Saharan Africa : Evidence from nationally representative health facility assessments. 2017;7(2).

  59. Marchant T, Tilley-Gyado RD, Tessema T, Singh K, Gautham M, Umar N, et al. Adding Content to Contacts: Measurement of High Quality Contacts for Maternal and Newborn Health in Ethiopia, North East Nigeria, and Uttar Pradesh, India. PLoS One. 2015 May;10(5).

  60. Munos MK, Maiga A, Do M, Sika GL, Carter ED, Mosso R, et al. Linking household survey and health facility data for effective coverage measures: A comparison of ecological and individual linking methods using the Multiple Indicator Cluster Survey in Côte d’Ivoire. J Glob Health. 2018;8(2).

  61. Ríos-Blancas MJ, Cahuana-Hurtado L, Lamadrid-Figueroa H, Lozano R. Effective coverage of treatment of hypertension in Mexican adults by states. Salud Publica Mex. 2017;59(2):154–64.

    PubMed  Google Scholar 

  62. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Pr. J Am Coll Cardiol. 2018;71(19):e127-248.

    Article  Google Scholar 

  63. Abariga SA, Al Kibria GM, Albrecht JS. Impact of the 2017 American College of Cardiology/American Heart Association Guidelines on Prevalence of Hypertension in Ghana. Am J Trop Med Hyg. 2020;102(6):1425–31.

    Article  Google Scholar 

  64. Kibria GMA, Swasey K, Kc A, Mirbolouk M, Sakib MN, Sharmeen A, et al. Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline. JAMA Netw open. 2018;1(3):e180606.

    Article  Google Scholar 

  65. Mahdavi M, Parsaeian M, Mohajer B, Modirian M, Ahmadi N, Yoosefi M, et al. Insight into blood pressure targets for universal coverage of hypertension services in Iran: The 2017 ACC/AHA versus JNC 8 hypertension guidelines. BMC Public Health. 2020;20(1):1–9.

    Article  Google Scholar 

  66. Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the Quality Chasm: A new health system for the 21st century [Internet]. Washington, D.C.: National Academies Press (US); 2001 [cited 2022 May 18]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK222274/

Download references

Acknowledgements

Not applicable

Funding

All authors were either employed or students at the Johns Hopkins Bloomberg School of Public Health. No financial support was given specifically for this review.

Author information

Authors and Affiliations

Authors

Contributions

The study outline was formulated by MP with contributions from OA, KR, and AE. MP and CN participated in the initial search, study selection, and data extraction. MP collated the extracted data and wrote the initial draft. All authors provided feedback and approved the final manuscript.

Corresponding author

Correspondence to Michael A. Peters.

Ethics declarations

Ethics approval and consent to participate

The study did not require ethical approval because the study was a review of published articles and did not include primary research on human subjects.

Consent to publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

  Approaches for measuring effective coverage

Additional file 2: 

Scoping review search strategy

Additional file 3: 

Quality assessment for studies included in framework development 

Additional file 4:

  World bank reports that incorporate measures of service quality to measures of hypertension service coverage 

Additional file 5: 

Full-text review dataset description of data

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Peters, M.A., Noonan, C.M., Rao, K.D. et al. Evidence for an expanded hypertension care cascade in low- and middle-income countries: a scoping review. BMC Health Serv Res 22, 827 (2022). https://doi.org/10.1186/s12913-022-08190-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12913-022-08190-0

Keywords

  • Hypertension
  • Hypertension management
  • Care cascade
  • Scoping review